Efficacy of Adjunctive Cariprazine in Patients With Major Depressive Disorder and Anxiety Symptoms: A Post Hoc Analysis

被引：0
|
作者：
Fava, Maurizio [1 ]
Maletic, Vladimir [1 ]
Chen, Chen [1 ]
Adams, Julie [1 ]
Kramer, Ken [1 ]
Kerolous, Majid [1 ]
机构：
[1] AbbVie, Madison, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2022年 / 47卷 / SUPPL 1期
关键词：
Cariprazine; Dopamine; Major Depressive Disorder; Anxiety;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P342
引用
收藏
页码：260 / 261
页数：2
相关论文
共 50 条
  • [41] Structural Brain Changes in Patients with Recurrent Major Depressive Disorder Presenting with Anxiety Symptoms
    Inkster, Becky
    Rao, Anil W.
    Ridler, Khanum
    Nichols, Thomas E.
    Saemann, Philipp G.
    Auer, Dorothee P.
    Holsboer, Florian
    Tozzi, Federica
    Muglia, Pierandrea
    Merlo-Pich, Emilio
    Matthews, Paul M.
    JOURNAL OF NEUROIMAGING, 2011, 21 (04) : 375 - 382
  • [42] Does anxiety increase impulsivity in patients with bipolar disorder or major depressive disorder?
    Bellani, Marcella
    Hatch, John P.
    Nicoletti, Mark A.
    Ertola, Astrid E.
    Zunta-Soares, Giovana
    Swann, Alan C.
    Brambilla, Paolo
    Soares, Jair C.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (05) : 616 - 621
  • [43] The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder
    Huang, Chun-Jen
    Lin, Ching-Hua
    Wu, Jyh-I
    Yang, Wei-Cheng
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2019, 22 (10) : 609 - 615
  • [44] The Centrality of Depression and Anxiety Symptoms in Major Depressive Disorder Determined Using a Network Analysis
    Park, Seon-Cheol
    Kim, Daeho
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 271 : 19 - 26
  • [45] Brexpiprazole as adjunctive treatment of major depressive disorder with anxious distress: Results from a post-hoc analysis of two randomised controlled trials
    McIntyre, Roger S.
    Weiller, Emmanuelle
    Zhang, Peter
    Weiss, Catherine
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 201 : 116 - 123
  • [46] The Centrality of Depression and Anxiety Symptoms in Major Depressive Disorder Determined Using a Network Analysis
    Park, Seon-Cheol
    Kim, Daeho
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S230 - S230
  • [47] Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity
    Lyndon, Gavin J.
    Prieto, Rita
    Wajsbrot, Dalia B.
    Allgulander, Christer
    Bandelow, Borwin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (03) : 110 - 118
  • [48] Noradrenergic-related Depression Symptoms in Patients with Major Depressive Disorder: Post Hoc Analysis of 5 Clinical Trials of Levomilnacipran Extended-release
    Blier, Pierre
    Gommoll, Carl
    Chen, Changzheng
    Lipschitz, Alan
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S362 - S363
  • [49] Lumateperone Treatment for Major Depressive Episodes With Mixed Features in Major Depressive Disorder and Bipolar I or Bipolar II Disorder: A Post Hoc Analysis of Anhedonia
    Durgam, Suresh
    Kozauer, Susan G.
    Earley, Willie R.
    Huo, Jason
    Escher, Tobie
    Yatham, Lakshmi N.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 199 - 200
  • [50] Risk Factors for Anxiety in Major Depressive Disorder Patients
    Xin, Li-Min
    Chen, Lin
    Ji, Zhen-Peng
    Zhang, Suo-Yuan
    Wang, Jun
    Liu, Yan-Hong
    Chen, Da-Fang
    Yang, Fu-De
    Wang, Gang
    Fang, Yi-Ru
    Lu, Zheng
    Yang, Hai-Chen
    Hu, Jian
    Chen, Zhi-Yu
    Huang, Yi
    Sun, Jing
    Wang, Xiao-Ping
    Li, Hui-Chun
    Zhang, Jin-Bei
    Si, Tian-Mei
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2015, 13 (03) : 263 - 268
12345